Skip Navigation LinksHome > December 2007 - Volume 50 - Issue 4 > The Transdermal Contraceptive Patch: An Updated Review of th...
Clinical Obstetrics & Gynecology:
doi: 10.1097/GRF.0b013e318159c410
Hormonal Contraception

The Transdermal Contraceptive Patch: An Updated Review of the Literature

O'CONNELL, KATHARINE MD, MPH*; BURKMAN, RONALD T. MD

Collapse Box

Abstract

The transdermal contraceptive patch which contains ethinyl estradiol and norelgestromin has an efficacy similar to current oral contraceptives (OCs). The major advantages include transdermal application and maintenance of adequate hormonal levels for at least 7 days. Side effects are similar to OC except for breast tenderness in the first 2 months of use and skin irritation at the application site. Although concern has been raised about a possible increased risk of venous thromboembolism, current available data comparing the patch to a norgestimate-containing OC ranges from no increase in risk to a 2.4-fold increase.

© 2007 by Lippincott Williams & Wilkins.

Login

Article Tools

Share

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.